NovaBone Products has opened a new dedicated Research and Development facility in Gainesville, Florida. The new 3,500 square foot facility provides the platform for NovaBone Products to implement its product development strategy and was completed in conjunction with the recent appointment of Gregory Pomrink as Vice President, Research & Development. Prior to joining NovaBone Products, Mr. Pomrink worked at Orthovita, Dentsply and Integra LifeSciences.
“Greg has the perfect background and experience to help NovaBone Products continue to grow sales at 50+% per year,” said Art Wotiz, President. “In fact, we have already seen breakthrough progress on key projects with our bioactive bone graft,” he added.
NovaBone Products has further committed additional staff and equipment for the new facility. “NovaBone has clearly demonstrated its commitment to new product development,” said Greg Pomrink. “I am honored to play a vital role in defining the future achievements of this company through product innovations.”
NovaBone pioneered silicon and calcium ion controlled release products that stimulate and accelerate the regeneration of cortical and cancellous bone. Since its inception in 2002, the company has developed numerous formulations and delivery systems of its patented, bioactive technology platform.